---
$id: https://graph.org.ai/products/commodity/51142035
$type: Product
source: UNSPSC
code: "51142035"
title: "Ziconotide"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ziconotide

**UNSPSC Code**: 51142035
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonnarcotic analgesic with the molecular formula C102H172N36O32S7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7I64C51O16, chemically known as omega-conotoxin m viia (reduced), cyclic (1-16),(8-20),(15-25)-tris(disulfide) but generally known as ziconotide, which bears US NIH Compound Identifier 16129690. European Medicines Agency schedules Ziconotide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00150MIG. The term ZICONOTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules ziconotide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule ziconotide under HS 29349990 and SITC 51579. As of Q4 2014, ZICONOTIDE remains the US FDA Preferred Term for this commodity. Ziconotide bears US NLM identifiers UMLS ID C0211011 and NCI Concept Code C1475. SMILES: CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC.

